Optipharm.CO.,LTD (KOSDAQ: 153710)

Optipharm.CO.,LTD Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	7,313	2,254	5,573	8,187	15,725	20,192
Short-Term Investments	7,758	13,396	11,048	13,919	6,444	5,320
Cash & Short-Term Investments	15,071	15,651	16,621	22,106	22,169	25,512
Cash Growth	-7.05%	-5.84%	-24.81%	-0.28%	-13.11%	-2.94%
Accounts Receivable	1,192	1,369	1,124	1,001	863.24	1,104
Other Receivables	770.49	268.86	972.95	173.3	172.83	64.44
Receivables	2,127	1,783	2,231	1,314	1,235	1,168
Inventory	1,452	1,320	1,099	1,056	716.88	673.79
Prepaid Expenses	357.45	327.28	316.77	497.53	981.89	89.61
Other Current Assets	1,378	1,395	1,279	893.95	573.7	588.04
Total Current Assets	20,385	20,476	21,548	25,867	25,676	28,032
Property, Plant & Equipment	18,124	18,325	17,717	13,613	13,347	13,177
Long-Term Investments	-0	0	985.74	986.09	986.39	66.12
Other Intangible Assets	287.44	281.51	258.4	263.82	272.36	245.08
Other Long-Term Assets	441.1	193.34	673.72	438.74	1,040	199.94
Total Assets	39,238	39,275	41,182	41,168	41,321	41,719
Accounts Payable	426.59	581.26	503.35	575.04	383.31	302.35
Accrued Expenses	261.06	437.63	101.92	76.1	68.29	63.82
Short-Term Debt	10,840	9,610	7,470	5,830	4,290	3,350
Current Portion of Leases	144	148.32	90.25	102.31	10.88	32.52
Other Current Liabilities	790.3	823.69	1,098	1,267	771.7	619.18
Total Current Liabilities	12,462	11,601	9,264	7,851	5,524	4,368
Long-Term Leases	181.73	287.95	164.08	47.15	179.84	175.28
Long-Term Unearned Revenue	1,495	887.03	1,146	324.51	225.72	23.19
Other Long-Term Liabilities	46.54	41.08	38.74	37.91	31.38	24.45
Total Liabilities	15,810	14,131	12,171	10,213	7,541	6,110
Common Stock	7,335	7,335	7,335	7,295	7,237	7,189
Additional Paid-In Capital	44,017	41,982	41,982	41,710	41,211	40,879
Retained Earnings	-27,427	-25,299	-22,404	-20,243	-16,990	-14,757
Comprehensive Income & Other	-497.02	1,127	2,098	2,193	2,321	2,299
Shareholders' Equity	23,428	25,144	29,011	30,955	33,780	35,609
Total Liabilities & Equity	39,238	39,275	41,182	41,168	41,321	41,719
Total Debt	11,166	10,046	7,724	5,979	4,481	3,558
Net Cash (Debt)	3,905	5,605	8,897	16,126	17,688	21,954
Net Cash Growth	-36.62%	-37.01%	-44.83%	-8.83%	-19.43%	0.36%
Net Cash Per Share	266.80	382.05	609.19	1110.10	1225.67	1541.06
Filing Date Shares Outstanding	14.67	14.67	14.67	14.59	14.47	14.38
Total Common Shares Outstanding	14.67	14.67	14.67	14.59	14.47	14.38
Working Capital	7,923	8,875	12,284	18,016	20,151	23,664
Book Value Per Share	1597.01	1714.00	1977.60	2121.75	2333.75	2476.67
Tangible Book Value	23,141	24,863	28,753	30,691	33,507	35,364
Tangible Book Value Per Share	1577.42	1694.81	1959.99	2103.67	2314.93	2459.63
Land	3,583	3,583	3,583	3,583	3,583	3,583
Buildings	10,507	14,380	10,936	10,403	10,392	10,392
Machinery	3,249	8,220	6,909	5,776	5,224	4,377
Construction In Progress	49.23	-	3,128	573.74	12.4	-

Source: S&P Capital IQ. Standard template. Financial Sources.